chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Dyspnoea, Electrocardiogram, Hyperhidrosis
Clinical narrative: Can?t catch my breath- dizziness- vertigo-shaking-sweating-loss of Appetite-heart arrhythmias- vision issues- foul taste in mouth- foul smelling sweat - nausea - diarrhea-  Feeling like I?m going to pass out - muscle aches and spasms  Overall weakness
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Myalgia, Nausea, Parosmia, Taste disorder
Clinical narrative: Can?t catch my breath- dizziness- vertigo-shaking-sweating-loss of Appetite-heart arrhythmias- vision issues- foul taste in mouth- foul smelling sweat - nausea - diarrhea-  Feeling like I?m going to pass out - muscle aches and spasms  Overall weakness
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Ultrasound scan, Vertigo, Visual impairment, X-ray
Clinical narrative: Can?t catch my breath- dizziness- vertigo-shaking-sweating-loss of Appetite-heart arrhythmias- vision issues- foul taste in mouth- foul smelling sweat - nausea - diarrhea-  Feeling like I?m going to pass out - muscle aches and spasms  Overall weakness
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Vaccine breakthrough infection
Clinical narrative: Breakthrough Covid-19 Hospitalization: A 63-year-old FEMALE presents to Emergency Room on 12/02/21 11:07 with Chief Complaint: sob, + c.         Active Inpatient Medications                           Status   1)   ACETAMINOPHEN TAB  2 TABLETS PO Q6H PRN FOR MILD PAIN  ACTIVE          OR FEVER. ALTERNATE WITH IBUPROFEN IF USED FOR          FEVER (max 4,000mg APAP/24hrs from all sources)   2)   ALBUTEROL HFA INHL,ORAL  2 PUFFS PO Q4H PRN for        ACTIVE          dyspnea or wheezing (use with spacer)   3)   ASPIRIN TAB,EC  81MG PO DAILY                          ACTIVE   4)   BARICITINIB TAB  2MG PO DAILY                          ACTIVE   5)   BENZONATATE CAP,ORAL  100MG PO Q8H PRN FOR DRY COUGH   ACTIVE   6)   ELECTROLYTE POWDER,ORAL  1 PACKET IN 1 QUART OF WATER  ACTIVE          AND DRINK PO BID PRN FOR DIARRHEA   7)   ENOXAPARIN INJ  40MG/0.4ML SQ Q24H                     ACTIVE   8)   FAMOTIDINE TAB  20MG PO HS                             ACTIVE   9)   IBUPROFEN 400MG UD TAB  400MG PO Q6H PRN FOR MODERATE  ACTIVE          PAIN OR FEVER. ALTERNATE WITH APAP IF USED FOR          FEVER   10)  MOMETASONE FUROATE 220MCG INHL,ORAL  1 INHALATION      ACTIVE          INHL ORAL DAILY   11)  MONTELUKAST TAB  10MG PO DAILY                         ACTIVE   12)  ONDANSETRON TAB,ORAL DISINTEGRATING  4MG ODT BID PRN   ACTIVE          PRN FNV   13)  REMDESIVIR INJ REMDESIVIR 100 MG in SODIUM CHLORIDE    ACTIVE          0.9% 100 ML  INFUSE OVER 30 Minutes IVPB Q24H   14)  diphenhydrAMINE CAP,ORAL  25MG PO Q6H PRN FOR          ACTIVE          COUGH/INSOMNIA/RASH/ITCHING   15)  guaiFENesin TAB  ONE (1) TABLET PO Q4H PRN FOR WET     ACTIVE          COUGH  Patient is being discharged from HOSPITAL to Family  Care Unit today DEC 06, 2021.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: pt is 27 weeks pregnant, 122.90 pounds at date the vaccine was administered. estimated due date March 8th
Age: 55.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product administration error, Product storage error
Clinical narrative: Administration error, given past beyond use date, no adverse event associated
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Feeling abnormal, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: On December 06, 2021 I began feeling bad, sore throat, Dry cough, Dec 8th cough increased, tested for COVID 19 on the Dec 9th, postive for COVID 19. Break through infection  I had my third dose- booster on 11/30/2021 Moderna.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Cough, Dyspnoea, Hypoxia, Myalgia
Clinical narrative: signs and symptoms:  SOB, cough, myalgias,  hypoxic.  Pneumonia, acute respiratory failure,  treatment: IV steroids, breathing tx, oxygen, remdesivir
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia
Clinical narrative: signs and symptoms:  SOB, cough, myalgias,  hypoxic.  Pneumonia, acute respiratory failure,  treatment: IV steroids, breathing tx, oxygen, remdesivir
Age: 45.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product administration error, Product storage error
Clinical narrative: Administration error, given past beyond use date, no adverse event associated
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse reaction noted.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: NO ADVERSE EVENT  (Vaccine Storage Excursion)
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Dysgeusia, Nasal congestion
Clinical narrative: cough, nasal congestion, bad taste in mouth starting 12/13/21
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Computerised tomogram normal, Electrocardiogram normal, Hypersensitivity, Pain
Clinical narrative: Body Aches, aching joints everywhere, it hurt to walk, ongoing pain focused on hands and wrists joints. In addition to the symptoms experienced allergic reaction, the doctor said it was a sinus infection. Referred to a cardiologist for ongoing treatment. The doctor diagnosed me with tendonitis.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Sinusitis, Tendonitis, X-ray normal
Clinical narrative: Body Aches, aching joints everywhere, it hurt to walk, ongoing pain focused on hands and wrists joints. In addition to the symptoms experienced allergic reaction, the doctor said it was a sinus infection. Referred to a cardiologist for ongoing treatment. The doctor diagnosed me with tendonitis.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse event. Received 4th dose two weeks after receiving booster vaccine
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Balance disorder, Central nervous system lesion, Chest pain, Hypoaesthesia
Clinical narrative: On 6/8/2021, he developed numbness on chest, back fingers and toes.  By 7/8/2021, symptoms had improved with mild residual paresthea in fingers and teos.  On 8/5/2021, he developed numbness in right lower limb.  On 8/6/2021, right leg became weak, and balance was impaired.  He also developed superficial pain in chest and abdomen.  By the time of visit in neurology clinic 11/16/2021, most symptoms had resolved, but abnormal sensation in left foot has persisted.  MRI brain, C spine and Ts spine w and w/o contrast 11/24/2021 showed two T2 hyperintense lesion in spinal cord, one at C2 and T1-2.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging abnormal, Magnetic resonance imaging head, Magnetic resonance imaging neck, Muscular weakness, Neurological examination
Clinical narrative: On 6/8/2021, he developed numbness on chest, back fingers and toes.  By 7/8/2021, symptoms had improved with mild residual paresthea in fingers and teos.  On 8/5/2021, he developed numbness in right lower limb.  On 8/6/2021, right leg became weak, and balance was impaired.  He also developed superficial pain in chest and abdomen.  By the time of visit in neurology clinic 11/16/2021, most symptoms had resolved, but abnormal sensation in left foot has persisted.  MRI brain, C spine and Ts spine w and w/o contrast 11/24/2021 showed two T2 hyperintense lesion in spinal cord, one at C2 and T1-2.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia, Scan with contrast, Sensory disturbance
Clinical narrative: On 6/8/2021, he developed numbness on chest, back fingers and toes.  By 7/8/2021, symptoms had improved with mild residual paresthea in fingers and teos.  On 8/5/2021, he developed numbness in right lower limb.  On 8/6/2021, right leg became weak, and balance was impaired.  He also developed superficial pain in chest and abdomen.  By the time of visit in neurology clinic 11/16/2021, most symptoms had resolved, but abnormal sensation in left foot has persisted.  MRI brain, C spine and Ts spine w and w/o contrast 11/24/2021 showed two T2 hyperintense lesion in spinal cord, one at C2 and T1-2.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Electric shock sensation, Seizure, Tremor
Clinical narrative: Chills, shaking to the point of convulsions, feelings of shocks through hips, back and legs.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Blood test normal
Clinical narrative: Hair loss
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Booster given to early (4 months instead of 6 months)
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash
Clinical narrative: Covered upper half of left arm and didn't hurt or itch. Sought PCP to identify and was advised to leave it alone unless it got worse. Rash went away in 2 weeks with no treatment. No other issues to report.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Tinnitus
Clinical narrative: Severe tinnitus/unable to sleep the evening of immunization. Improved the next day
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No Adverse reaction. was given 4th dose after receiving booster two weeks prior.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: Patient contracted COVID after  being fully vaccinated.  No Booster. Asymptomatic exposure.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Breakthrough Covid-19 Hospitalization  ER Triage Note    a 68 year old FEMALE presents to Emergency   Department on 12/02/21 10:59.         Active Inpatient Medications                           Status ========================================================================   1)   ACETAMINOPHEN TAB  2 TABLETS PO Q6H PRN FOR MILD PAIN  ACTIVE          OR FEVER. ALTERNATE WITH IBUPROFEN IF USED FOR          FEVER (max 4,000mg APAP/24hrs from all sources)   2)   APIXABAN TAB,ORAL  10MG PO Q12H                        ACTIVE   3)   ATORVASTATIN TAB  40MG PO DAILY                        ACTIVE   4)   BENZONATATE CAP,ORAL  100MG PO Q8H PRN FOR DRY COUGH   ACTIVE   5)   DEXTROSE 50% INJ,SOLN  25 GRAMS IV PUSH Q15M PRN FOR   ACTIVE          HYPOGLYCEMIA WHEN PATIENT IS UNRESPONSIVE AND          GLUCOSE IS LESS THAN 70  ***NOTIFY PHYSICIAN*** ->          REASSESS IN 15 MINUTES AND CONTINUE WITH          HYPOGLYCEMIA PROTOCOL   6)   DEXTROSE GEL,ORAL  15.5 mL (1/2 TUBE, 12 gm GLUCOSE)   ACTIVE          PO Q15M PRN FOR HYPOGLYCEMIA WHEN PATIENT IS          RESPONSIVE AND GLUCOSE IS 50-70  -> REASSESS IN 15          MINUTES AND CONTINUE WITH HYPOGLYCEMIA PROTOCOL   7)   DEXTROSE GEL,ORAL  31 mL (1 TUBE, 24 gm GLUCOSE) PO    ACTIVE          Q15M PRN FOR HYPOGLYCEMIA WHEN PATIENT IS          RESPONSIVE AND GLUCOSE IS LESS THAN 50 ***NOTIFY          PHYSICIAN*** -> REASSESS IN 15 MINUTES AND CONTINUE          WITH HYPOGLYCEMIA PROTOCOL   8)   ELECTROLYTE POWDER,ORAL  1 PACKET IN 1 QUART OF WATER  ACTIVE          AND DRINK PO BID PRN FOR DIARRHEA   9)   FAMOTIDINE TAB  20MG PO HS                             ACTIVE   10)  GLUCAGON INJ  1MG/1VIAL IM ONCE PRN FOR HYPOGLYCEMIA   ACTIVE          WHEN PATIENT UNRESPONSIVE AND NO IV ACCESS          ***NOTIFY  PHYSICIAN*** -> REASSESS IN 15 MINUTES          AND CONTINUE WITH HYPOGLYCEMIA PROTOCOL.          SUBCUTANEOUS ALLOWED.   11)  INSULIN ASPART INJ  CORRECTIONAL PROTOCOL SQ HS BG     ACTIVE          <70=PROTOCOL; 70-175=0 UNIT; 176-200=1 UNIT;          201-225=2 UNITS; 226-250=3 UNITS; 251-300=4 UNITS;          301-350=5 UNITS; 351-400=6 UNITS; >400=7 UNITS   12)  INSULIN ASPART INJ  MILD CORRECTIONAL PROTOCOL SQ      ACTIVE          WITH MEALS BG <70=PROTOCOL; 71-150=0 UNIT;          151-175=1 UNIT; 176-200=2 UNITS; 201-225=3UNITS;          226-250=4 UNITS; 251-300=6 UNITS; 301-350=8 UNITS;          351-400=10 UNITS; >400=12 UNITS   13)  INSULIN GLARGINE PREFILLED PEN INJ  18 UNITS SQ QDAY   ACTIVE   14)  LOSARTAN TAB  25MG PO DAILY HOLD FOR SBP less than     ACTIVE          135   15)  METOPROLOL TARTRATE (IR) TAB  12.5MG PO BID hold for   ACTIVE          sbp less than 130 or HR less than 60   16)  ONDANSETRON TAB,ORAL DISINTEGRATING  4MG ODT BID PRN   ACTIVE          PRN FNV   17)  REMDESIVIR INJ REMDESIVIR 100 MG in SODIUM CHLORIDE    ACTIVE          0.9% 100 ML  INFUSE OVER 30 Minutes IVPB Q24H   18)  guaiFENesin TAB  ONE (1) TABLET PO Q4H PRN FOR WET     ACTIVE          COUGH   Patient is being discharged from HOSPITAL  Care Unit today DEC 08, 2021
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dry skin, Nausea, Skin warm
Clinical narrative: About 5 min  after inj, pt c/o dizziness. Pt is fully awake, alert, coherent. Skin warm/dry. Color n/l. Resp easy/reg. 1215 bp sitting 88/48 -HR 55/m -RR 18/m. Then, c/o nausea. 1220p bp sitting on floor now 163/76 HR 69/m. When asked last meal, he only had cup of tea. Reg oj given. Tol sips. 1225 bp sitting 121/102 HR 55/m RR 18 reg. Per pt, feeling better. 1235 instr to eat lunch. In the future if going for vaccination, to inform Provider about his anxiety w  injection. Left store ambulatory , stable w wife.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Death, Decreased appetite, Dyspnoea
Clinical narrative: hospitilization, death, progressive weakness, SOB, decreased appetite, unknown symptom onset
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: hospitilization, death, progressive weakness, SOB, decreased appetite, unknown symptom onset
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Flushing, Hyperhidrosis, Nerve compression, Neuralgia
Clinical narrative: 11mins post vaccination pt reported flushing/sweating, pinched spine nerve pain, and dizziness Vitals: 109/58, 72, 18, 100% Pt stable and released from the vaccination site
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Inadvertently given Pfizer Peds dose instead of Pfizer age 12 and older dose. Dose 2 will be Pfizer 12 and older.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site bruising, Pyrexia, Tinnitus
Clinical narrative: Abnormal bruising at the injection site.  Fever of 102.2 (my baseline is 97.7).  Horrible headache lasting for 11 days, resolving on the 12th day.  I have experienced tinnitus ever since my injection.  I have been hoping it would go away, but the tinnitus persists to this day.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Lymphadenopathy, Nausea, Rash
Clinical narrative: dizziness, rash, headache, nausea, swollen under arm
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No Adverse reaction. Resident received 4th dose 1.5 months after receiving 3rd dose.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Booster given to early (4 months instead of 6 months)
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Booster dose given too early. Second dose in series was given 8/27/2021
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Electrocardiogram, Headache, Laboratory test
Clinical narrative: weakness, hedache, chills
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper
Clinical narrative: Persistent stomach pain after vaccine, top left side of stomach near heart
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Grip strength decreased, Limb discomfort, Mobility decreased, Pain in extremity
Clinical narrative: left arm painful, difficulty using arm at all, feels heavy, cant hold things
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test abnormal, Chest X-ray abnormal, Hypersensitivity, Pruritus, Rash
Clinical narrative: Head to toe rash with hives all over body scratchy  and itchy with itchy throat. I was already pre-medicated with dexamethasone and benadryl.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation, Urticaria
Clinical narrative: Head to toe rash with hives all over body scratchy  and itchy with itchy throat. I was already pre-medicated with dexamethasone and benadryl.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Feeling cold, Injection site pain, Oropharyngeal pain
Clinical narrative: On the morning of December 8, I experienced the same symptoms as when I took the J&J a few months ago. I had chills and couldn't get warm. I was at home and put on a hoodie, coat and gloves and still couldn't get warm. My right arm was very sore. I wanted to lay down and go to bed but I'm working from home, so it made for a rough day. I was in bed early. The next day the chills were gone but I had a slightly sore throat and cough. I felt as if I was coming down with a cold. That lasted for the rest of the day. By Friday, December 10, I had no symptoms at all.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased, Chest X-ray, Chest pain, Dizziness, Electrocardiogram
Clinical narrative: Pt became dizzy and lightheaded with blurry vision approx. 30 minutes post vaccine. She also reported left sided chest pain. She was taken to ER. Declined steroid injection. EKG and chest xray were normal. Was discharged to home and will follow up with her PCP.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Pt became dizzy and lightheaded with blurry vision approx. 30 minutes post vaccine. She also reported left sided chest pain. She was taken to ER. Declined steroid injection. EKG and chest xray were normal. Was discharged to home and will follow up with her PCP.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID-19 case.
Age: 61.0
Sex: F
Vaccine: TDAP, VARZOS
Symptoms: Arthralgia, Chills, Headache, Inappropriate schedule of product administration, Myalgia
Clinical narrative: Shingles vaccine given at the same time as TDAP.  Experienced headache, fever, chills, muscle pain, and joint pain.
Age: 61.0
Sex: F
Vaccine: TDAP, VARZOS
Symptoms: Pyrexia
Clinical narrative: Shingles vaccine given at the same time as TDAP.  Experienced headache, fever, chills, muscle pain, and joint pain.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Rash, Tachycardia
Clinical narrative: RASH TACHYCARDIA AND PALPITATIONS
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Hepatic encephalopathy, Intensive care, Pain, Pyrexia
Clinical narrative: The patient is a 59 year old FEMALE who is being admitted to the  Hospital. This patient meets inpatient level of care because  hepatic encephalopathy and covid.         Active Inpatient Medications                           Status   ========================================================================   =   1)   ACETAMINOPHEN TAB  2 TABLETS PO Q6H PRN FOR MILD PAIN  ACTIVE          OR FEVER. ALTERNATE WITH IBUPROFEN IF USED FOR          FEVER. NTE 2G APAP DAILY FROM ALL SOURCES   2)   ASPIRIN TAB,EC  81MG PO QDAY                           ACTIVE   3)   ASPIRIN TAB,EC  325MG PO DAILY                         ACTIVE   4)   ENOXAPARIN INJ  40MG/0.4ML SQ Q24H                     ACTIVE   5)   LACTULOSE SOLN,ORAL  40GM/60ML PO BID (0700-1630)      ACTIVE          SCHEDULED   6)   MAGNESIUM OXIDE TAB  400MG PO BID                      ACTIVE   7)   ONDANSETRON TAB,ORAL DISINTEGRATING  4MG ODT BID PRN   ACTIVE          PRN FNV   8)   POTASSIUM CHLORIDE TAB,SA  20MEQ PO QDAY               ACTIVE   9)   REMDESIVIR INJ REMDESIVIR 100 MG in SODIUM CHLORIDE    ACTIVE          0.9% 100 ML  INFUSE OVER 30 Minutes IVPB Q24H  Antiviral Assessment   Remdesivir 200mg/250ml NS over 60 minutes given at 0651  Indication:  Covid   Anticipated duration:   5 days  Patient is still in the hospital
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Booster given to early (4 months instead of 6 months)
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Product administration error, Underdose
Clinical narrative: I am reporting an error that happened on the day of booster shot. I received the booster shot at my doctor's office; however, I did not get a full dosage of booster vaccine because the syringe malfunctioned. A good amount of liquid gushed out of syringe after I received the shot. I requested another shot. The clinic refused to give me another shot because they said they are instructed not to repeat vaccine. I searched on the website and found 'administration errors revaccination guidance' showing to repeat vaccine right away when lower than authorized or unknown dose (volume) of the correct formulation administered. I let the clinic know this info and they still refuse to give me another shot.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Flushing, Hyperhidrosis, Nausea, Pain in extremity
Clinical narrative: Covid Clinic. Approx 0945 Patient was given her Moderna Vaccine booster dose during the moderna booster dose clinic.   Within 2-3 minutes of getting her vaccine, the patient appeared that she needed help. Her Mother was with her and grasped her right arm, and the watch nurse took her left arm, she walked to a less crowded area, and was provided with privacy and was lowered into a supine position. Her vitals where taken and she was observed with constant monitoring for >30min.   Patient C/O mild nausea, flushing, and sweating. Pt reported feeling faint. Pt ABC's were monitored and vitals were noted as follows.  0948 Radial Pulse >108, resp>19, oblivious mild anxiety s/s 0950 P97, R16, B/P 110/82, 98%o2 RA 0955 P92, R14, 99% 1010 P103, R15, 97% 1015 P95, R15, 99% 1025 P98, R15, B/P 98/68, 98%  Patient affect pleasant, observed anxiety s/s, lightly flush skin, EOMs, Perral, and No vomiting, and no fall. Patients pulse UE/LE 3+, Apical Heart rate matches radial pulse, airway clear and maintained, and breathing with no distress. Heart sounds s1s2, and rapid pulse >100 was noted in vitals.   Patient was at 1010 moved to a seating position, and reported feeling faint, light headed. 1025 Patient was moved to a chair in a seated position and reported feeling better. 1033 Patient was monitored, and was encouraged to walk while the nurse maintained close contact to prevent the patient from falling, the patient was able to walk approx 50 yards with difficulty. Patient was reassessed for stable vitals, and vitals where WNL, and Patient was walked to her mothers car. Patient was encouraged and monitored for use of seat belt. Patient was wearing a correctly applied seat belt upon leaving the mall area and nurses watch.   Patient was encouraged to see her primary care provider, and to limit activity as needed to maintain her safety if she continued to feel anxiety.   Patients Meds are as follows Mirtazapine Lo Loestrin Cetirizine  2nd Note Follow up: 12-15-2021 approx 1400 Patient was called and reported that her only problem was a sore right arm and no other reported s/s to the nurse.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Lip swelling, Pruritus, Swelling face
Clinical narrative: Swelling of face, itchy skin on face and swelling of lips
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased, Blood pressure increased
Clinical narrative: I had been doing the vsafe check-ins and it came in yesterday and it was the same day I went to the doctor for my annual exam. when they tested my glucose it was extremely high which it had never been before. I wasn't displaying symptoms but it was caught because of my annual report.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Diarrhoea, SARS-CoV-2 test positive, Syncope, Vomiting
Clinical narrative: hospitilization, syncope, diarrhea, vomiting, unknown symptom onset date  3rd dose Pfizer vaccine given 12/1/21, Lot # FJ8762, IM RUD
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Disturbance in attention, Feeling abnormal, Injection site pain, Lethargy
Clinical narrative: Vertigo (fairly severe), malaise, difficulty concentrating, lethargy, soreness at injection site, loss of appetite, mild muscle weakness. After 36 hours, only soreness at injection site and residual vertigo and mental "fogginess".
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Muscular weakness, Vertigo
Clinical narrative: Vertigo (fairly severe), malaise, difficulty concentrating, lethargy, soreness at injection site, loss of appetite, mild muscle weakness. After 36 hours, only soreness at injection site and residual vertigo and mental "fogginess".
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Cataract, Ophthalmological examination, Vision blurred
Clinical narrative: Vision problems. After vaccine injection i had mild blurred vision for 3 days and stopped, 2 months later started to notice some vision issues but not till October 2021 5 months after J&J vaccine did i see a drastic change. I had an eye exam March 2021 and was fine other the normal small vision change upgrading lenses. Nothing about having cataracts, I just had an exam  & he said that I had cataracts, one eye is blurry so it had a big effect on my vision.  on a scale of 1-4 as he mentioned, I am at 1.5 cataracts. He had mentioned that he has personally notice & some of his colleagues said there is some documentation that the Vaccines can speed up cataract growth. And he said i figured there's no way to know for sure, for me that big of a change in a few months makes it a credible possible problem.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Booster given to early (4 months instead of 6 months)
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: NO ADVERSE EVENT  (Vaccine Storage Excursion)
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Laboratory test normal
Clinical narrative: Pt received all 3 vax After her second vax on 3/31/2021 Pt said she had massive hair loss  Pt said she had hair loss after the first vax but the second and third vax made hair loss worse
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, C-reactive protein normal, Chest X-ray normal, Electrocardiogram normal, Myocarditis
Clinical narrative: post vaccine myocarditis, symptoms 2 days after vaccination, came in the morning of 12/10. CXR and EKG normal, CRP 1.1 (mildly elevated) troponin 7.94 (elevated. Admitted to a local Hospital
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin increased
Clinical narrative: post vaccine myocarditis, symptoms 2 days after vaccination, came in the morning of 12/10. CXR and EKG normal, CRP 1.1 (mildly elevated) troponin 7.94 (elevated. Admitted to a local Hospital
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema
Clinical narrative: red ring aound injection site
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Patient c/o whole body rash  on 12/ 15 after recieving pfizer on 12/13/21. Patient seen by primary care center on 12/15/21 given benedryl.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Influenza virus test negative, Myalgia, Paraesthesia, SARS-CoV-2 test negative
Clinical narrative: Diffuse myalgias, arthralgias, bilateral hand and arm paresthesias
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Fatigue, Headache, Pain, Pain in extremity
Clinical narrative: Shingles Vaccine given at 5pm.  Painful arm and shoulder complex after admin and teeth hurt ( who knows??) 5 am next day low grade fever (99.8), severe body aches, headaches, joint pain, general fatigue which was consistent all day.  Not helped by advil every 4 hours. Could not lift my vaccine arm above my head due to pain 2nd day after returned to near normal with the exception of teeth pain...
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia, Toothache
Clinical narrative: Shingles Vaccine given at 5pm.  Painful arm and shoulder complex after admin and teeth hurt ( who knows??) 5 am next day low grade fever (99.8), severe body aches, headaches, joint pain, general fatigue which was consistent all day.  Not helped by advil every 4 hours. Could not lift my vaccine arm above my head due to pain 2nd day after returned to near normal with the exception of teeth pain...
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Anticoagulant therapy, Back pain, Blood test, C-reactive protein increased
Clinical narrative: Day 2 (Saturday) following vaccination I became short of breath with pain in my chest and back. Was seen 4 days after vaccination (Monday, November 8th) and after subsequent testing, discovered a Pulmonary Embolism. Monday, November 8th I went into a walk-in clinic. Testing was done to include Covid-19, influenza, as well as blood work to include troponin and metabolic panel, x-ray and EKG completed. Troponin was elevated and was advised to be admitted to local hospital for further testing. Following admittance to hospital, further bloodwork drawn as well as troponin testing, which leveled out. D-dimer and C-reactive protein came back elevated. Ultrasound testing was done on legs and a CTA chest scan. CT showed multiple clots in lungs. Was put on a heparin drip until release the following day. Am currently on xarelto to help break up clots.  No clotting issues prior, no travel, no surgery, no immobility, no birth control used and no smoking.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Electrocardiogram, Fibrin D dimer increased, Influenza virus test
Clinical narrative: Day 2 (Saturday) following vaccination I became short of breath with pain in my chest and back. Was seen 4 days after vaccination (Monday, November 8th) and after subsequent testing, discovered a Pulmonary Embolism. Monday, November 8th I went into a walk-in clinic. Testing was done to include Covid-19, influenza, as well as blood work to include troponin and metabolic panel, x-ray and EKG completed. Troponin was elevated and was advised to be admitted to local hospital for further testing. Following admittance to hospital, further bloodwork drawn as well as troponin testing, which leveled out. D-dimer and C-reactive protein came back elevated. Ultrasound testing was done on legs and a CTA chest scan. CT showed multiple clots in lungs. Was put on a heparin drip until release the following day. Am currently on xarelto to help break up clots.  No clotting issues prior, no travel, no surgery, no immobility, no birth control used and no smoking.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test, Pulmonary embolism, Pulmonary thrombosis, SARS-CoV-2 test, Troponin increased
Clinical narrative: Day 2 (Saturday) following vaccination I became short of breath with pain in my chest and back. Was seen 4 days after vaccination (Monday, November 8th) and after subsequent testing, discovered a Pulmonary Embolism. Monday, November 8th I went into a walk-in clinic. Testing was done to include Covid-19, influenza, as well as blood work to include troponin and metabolic panel, x-ray and EKG completed. Troponin was elevated and was advised to be admitted to local hospital for further testing. Following admittance to hospital, further bloodwork drawn as well as troponin testing, which leveled out. D-dimer and C-reactive protein came back elevated. Ultrasound testing was done on legs and a CTA chest scan. CT showed multiple clots in lungs. Was put on a heparin drip until release the following day. Am currently on xarelto to help break up clots.  No clotting issues prior, no travel, no surgery, no immobility, no birth control used and no smoking.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan, X-ray
Clinical narrative: Day 2 (Saturday) following vaccination I became short of breath with pain in my chest and back. Was seen 4 days after vaccination (Monday, November 8th) and after subsequent testing, discovered a Pulmonary Embolism. Monday, November 8th I went into a walk-in clinic. Testing was done to include Covid-19, influenza, as well as blood work to include troponin and metabolic panel, x-ray and EKG completed. Troponin was elevated and was advised to be admitted to local hospital for further testing. Following admittance to hospital, further bloodwork drawn as well as troponin testing, which leveled out. D-dimer and C-reactive protein came back elevated. Ultrasound testing was done on legs and a CTA chest scan. CT showed multiple clots in lungs. Was put on a heparin drip until release the following day. Am currently on xarelto to help break up clots.  No clotting issues prior, no travel, no surgery, no immobility, no birth control used and no smoking.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary mass, Pain in extremity
Clinical narrative: MY ARM HURST AND THERE A A LARGET THAN GRAPeFRUIT LUMP under my left arm
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: PATIENT DID NOT EXPERIENCE ANY ADVERSE EVENTS POST-VACCINE
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Booster given to early (4 months instead of 6 months)
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood test, Chest X-ray, Chest discomfort, Chest pain
Clinical narrative: Pericarditis. Chest tightness, palpitations, weakness and fatigue. So far treated with colchicine but still unresolved
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Fatigue, Palpitations, Pericarditis
Clinical narrative: Pericarditis. Chest tightness, palpitations, weakness and fatigue. So far treated with colchicine but still unresolved
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Patient given undiluted 0.3ml Dose or approximately 6 doses. Patient waited approximately 25 minutes and spoke with assistant medical director and stated he is feeling fine at this time. Patient will follow up with provider vie telehealth on 12/20/2021
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Flushing, Peripheral swelling, Rash
Clinical narrative: Client states she developed a rash on her chest, flushing and feeling warm, but no itching after receiving Moderna  first and second dose.  Client also had swelling on vaccination arm. After first dose her symptoms appeared a day after vaccine. Client states the second time around her symptoms were less and client took Benadryl and Tylenol to help with symptoms for both instances. She denies going to emergency care or Doctor.  Symptoms subsided after some days. Client states she has an allergy to Papaya, where her face swells up. . Per CDC guidance, approval to proceed with COVID vaccine Pfizer was obtained from medical consult team. The client did not report any symptoms during the 15-minute observation period. RN educated client on possible adverse reactions and when to seek medical care.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Fatigue, Feeling abnormal, Hypersomnia
Clinical narrative: Night of injection, 12/13, Flonase sprays hurt quite a bit when sprayed, never before.  2 days later am still 'fuzzy headed', weak, reduced appetite, tired (spent most of yesterday sleeping).  Realize all are typical reactions (except the sinus sensitivity).  Was hoping with this reduced 1/2 dosage symptoms would not be as bad as after 2nd dose in April 2021.  But thought you should know that I'm having a stronger reaction than after the 2nd dose.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Sinus disorder
Clinical narrative: Night of injection, 12/13, Flonase sprays hurt quite a bit when sprayed, never before.  2 days later am still 'fuzzy headed', weak, reduced appetite, tired (spent most of yesterday sleeping).  Realize all are typical reactions (except the sinus sensitivity).  Was hoping with this reduced 1/2 dosage symptoms would not be as bad as after 2nd dose in April 2021.  But thought you should know that I'm having a stronger reaction than after the 2nd dose.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Coagulation test, Condition aggravated, Full blood count, Thrombocytopenia
Clinical narrative: exacerbation of thrombocytopenia
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: PATIENT DID NOT EXPERIENCE ANY ADVERSE EVENTS POST-VACCINATION.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Bradycardia, COVID-19, Chest X-ray abnormal, Confusional state, Death
Clinical narrative: Patient tested positive for COVID-19 on November 16, 2021.  EMS was called to Facility as the patient was hypoxic and confused.  Pt was transferred to the ED at Hospital, where she was found to be in hypercarbic respiratory failure.  Pt was placed on BiPAP.  Her respiratory status worsened.  The patient was intubated on November 24, 2021 through December 2, 2021.  Initial CXR showed bilateral pulmonary infiltrate consistent with COVID-19.  During the hospital course, the patient received dexamethasone and baricitinib.  Pt was also seen by Cardiology for bradycardia.  The patient had an echocardiogram done that showed normal ejection fraction with pulmonary pressure of 58 mmHg.  The patients hospital course at Hospital was further complicated by a urinary tract infection, treated with ciprofloxacin.  Since the patients extubation she had hoarseness and difficulty swallowing.  The patient was started on TPN for nutrition.  On admission to Hospital- on December 6, 2021 the patient was on Vapotherm with 40L and FiO2 of 65%.  The plan for while the patient was at Hospital was for her to continue on baricitinib and dexamethasone and Pulmonary was going to follow.  Pt was on TPN and a Doghoff was going to be placed and Tube feedings were going to start.  ENT was consulted for the hoarseness.  Pt was on a Precedex drip and the plan was to wean off of Precedex.  On admission to Hospital- the patient was a DNR/DNI.  On December 10, 2021 at 1620 the patient went Comfort Cares and on December 10, 2021 at 1707 patient expired.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Dysphonia, Echocardiogram normal, Endotracheal intubation, Fraction of inspired oxygen
Clinical narrative: Patient tested positive for COVID-19 on November 16, 2021.  EMS was called to Facility as the patient was hypoxic and confused.  Pt was transferred to the ED at Hospital, where she was found to be in hypercarbic respiratory failure.  Pt was placed on BiPAP.  Her respiratory status worsened.  The patient was intubated on November 24, 2021 through December 2, 2021.  Initial CXR showed bilateral pulmonary infiltrate consistent with COVID-19.  During the hospital course, the patient received dexamethasone and baricitinib.  Pt was also seen by Cardiology for bradycardia.  The patient had an echocardiogram done that showed normal ejection fraction with pulmonary pressure of 58 mmHg.  The patients hospital course at Hospital was further complicated by a urinary tract infection, treated with ciprofloxacin.  Since the patients extubation she had hoarseness and difficulty swallowing.  The patient was started on TPN for nutrition.  On admission to Hospital- on December 6, 2021 the patient was on Vapotherm with 40L and FiO2 of 65%.  The plan for while the patient was at Hospital was for her to continue on baricitinib and dexamethasone and Pulmonary was going to follow.  Pt was on TPN and a Doghoff was going to be placed and Tube feedings were going to start.  ENT was consulted for the hoarseness.  Pt was on a Precedex drip and the plan was to wean off of Precedex.  On admission to Hospital- the patient was a DNR/DNI.  On December 10, 2021 at 1620 the patient went Comfort Cares and on December 10, 2021 at 1707 patient expired.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Gastrointestinal tube insertion, Hypoxia, Lung infiltration, Parenteral nutrition, Positive airway pressure therapy
Clinical narrative: Patient tested positive for COVID-19 on November 16, 2021.  EMS was called to Facility as the patient was hypoxic and confused.  Pt was transferred to the ED at Hospital, where she was found to be in hypercarbic respiratory failure.  Pt was placed on BiPAP.  Her respiratory status worsened.  The patient was intubated on November 24, 2021 through December 2, 2021.  Initial CXR showed bilateral pulmonary infiltrate consistent with COVID-19.  During the hospital course, the patient received dexamethasone and baricitinib.  Pt was also seen by Cardiology for bradycardia.  The patient had an echocardiogram done that showed normal ejection fraction with pulmonary pressure of 58 mmHg.  The patients hospital course at Hospital was further complicated by a urinary tract infection, treated with ciprofloxacin.  Since the patients extubation she had hoarseness and difficulty swallowing.  The patient was started on TPN for nutrition.  On admission to Hospital- on December 6, 2021 the patient was on Vapotherm with 40L and FiO2 of 65%.  The plan for while the patient was at Hospital was for her to continue on baricitinib and dexamethasone and Pulmonary was going to follow.  Pt was on TPN and a Doghoff was going to be placed and Tube feedings were going to start.  ENT was consulted for the hoarseness.  Pt was on a Precedex drip and the plan was to wean off of Precedex.  On admission to Hospital- the patient was a DNR/DNI.  On December 10, 2021 at 1620 the patient went Comfort Cares and on December 10, 2021 at 1707 patient expired.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory failure, SARS-CoV-2 test positive, Urinary tract infection
Clinical narrative: Patient tested positive for COVID-19 on November 16, 2021.  EMS was called to Facility as the patient was hypoxic and confused.  Pt was transferred to the ED at Hospital, where she was found to be in hypercarbic respiratory failure.  Pt was placed on BiPAP.  Her respiratory status worsened.  The patient was intubated on November 24, 2021 through December 2, 2021.  Initial CXR showed bilateral pulmonary infiltrate consistent with COVID-19.  During the hospital course, the patient received dexamethasone and baricitinib.  Pt was also seen by Cardiology for bradycardia.  The patient had an echocardiogram done that showed normal ejection fraction with pulmonary pressure of 58 mmHg.  The patients hospital course at Hospital was further complicated by a urinary tract infection, treated with ciprofloxacin.  Since the patients extubation she had hoarseness and difficulty swallowing.  The patient was started on TPN for nutrition.  On admission to Hospital- on December 6, 2021 the patient was on Vapotherm with 40L and FiO2 of 65%.  The plan for while the patient was at Hospital was for her to continue on baricitinib and dexamethasone and Pulmonary was going to follow.  Pt was on TPN and a Doghoff was going to be placed and Tube feedings were going to start.  ENT was consulted for the hoarseness.  Pt was on a Precedex drip and the plan was to wean off of Precedex.  On admission to Hospital- the patient was a DNR/DNI.  On December 10, 2021 at 1620 the patient went Comfort Cares and on December 10, 2021 at 1707 patient expired.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Throat tightness
Clinical narrative: REPORTS SWELLING OF THE FACE AND TIGHTENING OF THE THROAT
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site rash, Injection site reaction, Pruritus, Rash erythematous
Clinical narrative: Red quarter sized rash on arm at injection site. Itchy, no pain.
Age: 62.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Given past beyond use date, no adverse event associated.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: PATIENT DID NOT EXPERIENCE ANY ADVERSE EVENTS POST-VACCINATION.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest discomfort, Computerised tomogram thorax abnormal, Dizziness, Lung infiltration
Clinical narrative: Patient arrived to the ED on 12/11/2021 with complaints of chest tightness radiating to back that started on 12/11 Denied shortness of breath, but reported dizziness.  Low grade temp 100.1 12/14/2021  Did not require intubation or ICU admission  No supplemental oxygen was needed Patient requested monoclonal antibody treatment, patient was directed to receive outpatient upon discharge
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Muscle tightness, Pneumonia, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient arrived to the ED on 12/11/2021 with complaints of chest tightness radiating to back that started on 12/11 Denied shortness of breath, but reported dizziness.  Low grade temp 100.1 12/14/2021  Did not require intubation or ICU admission  No supplemental oxygen was needed Patient requested monoclonal antibody treatment, patient was directed to receive outpatient upon discharge
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site extravasation, Underdose
Clinical narrative: Patient came into the clinic with parent for the 2nd PEDS Covid shot. Sight prepped and cleaned, shot injected into arm using z-track method and when pulling out the vanish point needle some of the vaccine was leaking down patient's arm. Full dose not given.  Patient rescheduled for 2nd PEDS dose 12/16/21.
Age: 28.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Loss of consciousness, Tremor
Clinical narrative: Patient was shaky and passed out about 5 minutes after receiving vaccines. She came to and said she felt fine, but was encouraged to go to the hospital to get checked out.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: PATIENT DID NOT EXPERIENCE ANY ADVERSE EVENTS POST-VACCINATION.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Pain
Clinical narrative: After my second vaccine, I was and still unable to lift my left arm over my head, or scratch my back using that arm without restriction and severe pain.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: 17 year old patient received Pfizer booster before age 18,  no adverse reaction
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Chest discomfort, Dyspnoea, Heart rate increased, Muscle spasms
Clinical narrative: Pericardia constant since the 13th of November.  Episodes of blood pressure over 160/120 with a heart rate of 120bpm. Shortness of breath, pressure on chest, muscle spams, tremors. Currently starting beta blockers and anti-inflammatory.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Pericarditis, Tremor
Clinical narrative: Pericardia constant since the 13th of November.  Episodes of blood pressure over 160/120 with a heart rate of 120bpm. Shortness of breath, pressure on chest, muscle spams, tremors. Currently starting beta blockers and anti-inflammatory.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Booster given to early (4 months instead of 6 months)
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: PATIENT DID NOT EXPERIENCE ANY ADVERSE EVENTS POST-VACCINATION.